Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I suggest you buy enough shares and vote against them being renominated for their position.
Funny how it’s voted on, and they ALL seem to be doing a good enough job to continue on.
Imagine…one day soon the CEO responsible for bringing to patients the best Alz drug to date , was for years called the worst CEO of Biotech by impatient/short peeps.
Pffft.
Sorry bud. If the leadership was weak, the co would have folded already.
Compound shelved and never heard from again.
Tomorrow is another day. No worries. WGT in the bag.
Why you sweating for?
*SMILES*
I’ll bet Anavex proves out to have the better Rett drug for patients.
Forget what those with $$ try to have you think.
Trying to get the attention of everyone before full data release.
Sure sounds like we are in for a treat…..unless your still short of course
Amazon could do it for less. Global delivery as well
Imagine if Amazon were to partner with Anavex. The $$ available. Decades of owning the CNS market. 3-71 being pushed through trials faster and ready for market once 2-73 has a generic available.
If there ever was a time for Bezos to drop some investment cash in Pharma…….
Bruh.
Never mind my Christmas wish rambling.
Mele Kalikimaka a Hauoli Makahiki Hou
One of the few times I’d have to agree with you…..partly.
Except never Biogen.
Just because kund doesn’t understand it, don’t make it stupid.
Most likely it’s saying go long, we have multiple x’s to achieve
but,but,but the falls….. and the headaches are not tolerable. Hahaha
Soon to come:
They could choke on the daily pill.
Man, some would just counter up to and through approval.
Just give it up already.
“Just a while ago, the AVXL share price cracked the $10 barrier, and is heading up. Combining the spreadsheet numbers with today’s, and future Anavex announcements, there will be massive AVXL share price increases. For those who can hold and see out for a year or more, generational wealth will be in sight — eventually realized.”
That’s the end game for the Longs.
Besides the forward splits, and possible dividends
Not even close. $1 up, for now, is nothing
I’d disagree with you there.
Anavex will fly once there’s sales. Till then, play the hold it down game.
That’s a pretty weak way to spin it.
Sure…..cause PR on a short week is what everyone does.
1st week of Dec I’d guess.
Oh my…core marketing doesn’t have their logo at the bottom either….
The sky is falling.
I’m curious why no new trials started yet
Man….even when there’s nothing to discuss, it’s the same ol people pumping/dumping the same ol bs.
So nice to live life outside of this board.
When there’s new info the company releases, the o.g. Posters come out of hibernation. Until then….
All the complaints lately about Missling news this and news that.
Let’s have a hypothetical situation where you go ahead and rid yourselves of Anavex stock.
Where oh where would you reinvest your money?
Seems like with all the complaints about the sp, there’s no better gamble than Anavex right now.
And when that data comes and goes yet we still are here in the teens….then what? I don’t care if Missling keeps data from the public, because data people don’t understand does nothing. Look at how all past data did and question yourself how the next data release will be different. As long as he or enough to know alls well that ends well…..is something I’d be fine with.
Why? Cause I’m not interested in the $20s or $40s
It’s those triple digits.
Of course we are getting there.
Who WE are depends.
Probably won’t be those begging for data right now
What part of TL met all endpoints you don’t understand?
Can’t PR that and release full data later that proves something else.
Re-read the filings.
He sold 1/2 to keep the other 1/2
Could you provide any spec of proof as to why it wouldn’t? Given how one p3 already read out?
Missling delaying and slow walking is not an option
Wow. Can’t attack the science so this is the best that can be done…..
Can’t trust Missling because what happened to another co.
Sticky worthy
I’m sure Gottlieb moved on from being lead person from the FDA cause he was tired as well….. sarcastic laugh. He knew BP would tirelessly try and get things approved. If ya can’t beat ‘em, join em.
Become a millionaire in the process
You understand that every p2 p2/3 trial met primary and secondary endpoints right?
Saying otherwise is down right comedic
As much as I’d love to believe that, was it really a coincidence the extended adult Rett data was released a few days before options were exercised?
As long as they continue to be positive is all that matter to me. The longer we stay beaten down, the more accumulation is possible.
Yes, I do add a few here and there as funds allow it.
Say Anavex DOES get Blarcamesine approved for Rett, then AD….how could a price tag be put on a buyout when A-371 is waiting for its turn to shine. If Sigmar1 gets the respect Amalyoid did, Anavex is in perfect position to be most envied.
Doesn’t seem like a buyout is what’s desired.
Which then brings us to where the SP is. Ignore.
The co was literally months away from bankruptcy before Missling was hired.
Thanks to whomever it was that posted that 2013 tidbit.
I THINK CTAD 2023 IN OCTOBER, the kraken will be released.
Come on now, SP doesn’t relate to how much a company is worth. It’s what the STREET wants you to think it’s worth.
Is SAVA really a better co than AVXL?
It’s happened many times over the years. This co has the next AD drug, that co has the next one. They all got pumped right into failed trials.
What an odd number to sell. Might as well have sold 273.
The good thing is that he stayed for 10 years to be awarded that option.
You know if there’s any further rewards down the road.
More in x years, if something goes to market
Same reasoning for naked shorting the ticker. Definitely worth the slap on the wrist to keep the sp suppressed.
How? It’s the easier of the two trials
Hard level vs easy….
Maybe that’s something that’s being discussed…..
Or not.
Shouldn’t take too long to figure out the baseline mg needed, per patient, to be within a range…..
Precision medicine. Up to 50mg Blarcamesine to maintain __ percent blood concentration. Each person requiring different mg to hit that mark across all indications.
It’s that simple.
That’s the holdup
I’d agree in that it’s the blood concentration vice amount of drug taken.
“By going the AA route, they
would need to initiate a confirmatory
trial per AA protocol. So all hands on
deck for AD trial? And all hands on
deck for RETT approval. That's my
guess.”
Imagine the rest of any trial for A-273 being confirmatory trials.
- Epilepsy
- “Undisclosed”, for I don’t know, 3 years already?
- and
- and
- and
Quickly appreciating as “the street” finally acknowledges the eye widening potential of this “ magic pill”
What’s faster to towards sales?
Going the AA route, knowing that it meets or surpasses the 2 recently approved therapies?
Or…
Using your newly discovered biomarker and trying to convince everyone that it is a better target than clearing out Plaques?